| GTO ID | GTC1026 |
| Trial ID | ChiCTR2300077482 |
| Disease | Glioblastoma |
| Therapy | CAR-T cell |
| Treatment | XYF13 CAR-T cells |
| Recruitment status | Recruiting |
| Title | A open-label study evaluating the safety, tolerability and preliminary efficacy of XYF13 Car-T in the patients with recurrent glioblastoma. |
| Year | 2023 |
| Country | China |
| Company sponsor | The First Affiliated Hospital of the Air Force Military Medical University |
| Cohort 1 | |||||||
|
|||||||